Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for global professionals · Tuesday, March 19, 2024 · 697,092,685 Articles · 3+ Million Readers

Injectable Drugs Therapeutics Development and Professional Review Analysis 2018

Injectable Drugs Market 2018 Competitor Information, Analysis, and Insights to Improve R&D Strategies 2023

PUNE , INDIA, March 16, 2018 /EINPresswire.com/ -- Summary
This report is the 6th edition of our long-running analysis of the injectables CMO industry. It provides an expert quantitative analysis on the latest trends and plans for outsourcing commercially approved injectable products. It combines the rich data resources of PharmSource and Pharmaceutical Intelligence Center with our 20 years’ experience in analyzing the injectables CMO industry to provide the most definitive, trustworthy source of strategic insight on this topic in the bio/pharmaceutical realm.

Scope
- The report is based on the most recent data on industry capacity, the injectables pipeline and the behaviors of the key biopharmaceutical industry actors.
- The model and assumptions are fully explained so you can understand how the analysis was driven and how conclusions were reached.

GET SAMPLE REPORT @ https://www.wiseguyreports.com/sample-request/3066682-pharmsource-demand-and-supply-for-contract-manufacturing-of

Reasons to buy
This 70-page report gives important, expert insight you won’t find in any other source. Over 25 tables and graphs throughout the report illustrate major points and trends. This report is required reading for -
- CMO executives who must have deep understanding of the injectables marketplace to make strategic planning and investment decisions.
- Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
- Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Table of Content: Key Points
Chapter 1: Executive Summary 1
Chapter 2: Objectives and Methodology 3
Methodology 3
Chapter 3: Recent Trends in Injectables NDA/BLA Approvals 5
Injectables approvals overview 5
NDA/BLA approvals of injectable products 6
Injectable NDA/BLA approvals by sponsor type 10
Processing and packaging characteristics 12
Contract manufacturing of injectable NDA/BLA approvals 15
European biosimilar approvals 18
Cytotoxic drug approvals 19
CMOs winning NDA/BLA approvals 20
What it means 21
Chapter 4: Injectables Pipeline 24
Pipeline Overview 24
Biosimilars 27
Cytotoxic and High Potency Pipeline 28
Pipeline Ownership 29
Pipeline by Route of Administration 31
Unit volumes 32
What it means 35
Chapter 5: Demand Forecast for CMO Capacity 36
…Continued

ACCESS REPORT @ https://www.wiseguyreports.com/reports/3066682-pharmsource-demand-and-supply-for-contract-manufacturing-of

Get in touch:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here

Powered by EIN Presswire


EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.

Submit your press release